Vortioxetine usage in an elderly patient with major depressive disorder and accompanied by multiple physical conditions: A case report

被引：1
作者：
Wang, Xiaoman [1 ]
Ma, Xiaoqian [2 ]
Long, Yicheng [2 ]
Wu, Guowei [2 ]
机构：
[1] Cent South Univ, XiangYa Sch Med, Changsha, Peoples R China
[2] Cent South Univ, Xiangya Hosp 2, Natl Clin Res Ctr Mental Disorders, Dept Psychiat, Changsha 410011, Peoples R China
来源：
AGING MEDICINE | 2023年 / 6卷 / 04期
关键词：
chronic physical conditions; major depressive disorder; vortioxetine; PLACEBO-CONTROLLED TRIALS; 2016 CLINICAL GUIDELINES; DOUBLE-BLIND; MULTIMODAL ANTIDEPRESSANT; CANADIAN NETWORK; LU AA21004; ADULTS; MANAGEMENT; SAFETY; MOOD;
D O I：
10.1002/agm2.12268
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
Elderly patients with depressive disorder always have complex and diverse symptoms, and are mostly combined with chronic physical conditions. This case report presents a case of vortioxetine usage in a 67-year-old male patient with major depressive disorder and accompanied by multiple physical conditions.image
引用
收藏
页码：446 / 449
页数：4
相关论文
共 20 条
  • [1] Efficacy and safety of vortioxetine in treatment of patients with major depressive disorder and common co-morbid physical illness
    Baldwin, David S.
    Necking, Oscar
    Schmidt, Simon Nitschky
    Ren, Hongye
    Reines, Elin H.
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2022, 311 : 588 - 594
  • [2] The safety and tolerability of vortioxetine: Analysis of data from randomized placebo-controlled trials and open-label extension studies
    Baldwin, David S.
    Chrones, Lambros
    Florea, Ioana
    Nielsen, Rebecca
    Nomikos, George G.
    Palo, William
    Reines, Elin
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2016, 30 (03) : 242 - 252
  • [3] Vortioxetine: Clinical Pharmacokinetics and Drug Interactions
    Chen, Grace
    Hojer, Astrid-Maria
    Areberg, Johan
    Nomikos, George
    [J]. CLINICAL PHARMACOKINETICS, 2018, 57 (06) : 673 - 686
  • [4] Cipriani Andrea, 2018, Focus (Am Psychiatr Publ), V16, P420, DOI 10.1176/appi.focus.16407
  • [5] Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study
    Conradi, H. J.
    Ormel, J.
    de Jonge, P.
    [J]. PSYCHOLOGICAL MEDICINE, 2011, 41 (06) : 1165 - 1174
  • [6] Guidelines for the diagnosis and treatment of depressive disorders in China: The second edition
    Feng, Yuan
    Xiao, Le
    Wang, Wei-Wei
    Ungvari, Gabor S.
    Ng, Chee H.
    Wang, Gang
    Xiang, Yu-Tao
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2019, 253 : 352 - 356
  • [7] Vortioxetine: A Review in Cognitive Dysfunction in Depression
    Frampton, James E.
    [J]. DRUGS, 2016, 76 (17) : 1675 - 1682
  • [8] Vortioxetine: a novel antidepressant for the treatment of major depressive disorder
    Gonda, Xenia
    Sharma, Samata R.
    Tarazi, Frank I.
    [J]. EXPERT OPINION ON DRUG DISCOVERY, 2019, 14 (01) : 81 - 89
  • [9] A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder
    Katona, Cornelius
    Hansen, Thomas
    Olsen, Christina Kurre
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2012, 27 (04) : 215 - 223
  • [10] Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments
    Kennedy, Sidney H.
    Lam, Raymond W.
    McIntyre, Roger S.
    Tourjman, S. Valerie
    Bhat, Venkat
    Blier, Pierre
    Hasnain, Mehrul
    Jollant, Fabrice
    Levitt, Anthony J.
    MacQueen, Glenda M.
    McInerney, Shane J.
    McIntosh, Diane
    Milev, Roumen V.
    Mueller, Daniel J.
    Parikh, Sagar V.
    Pearson, Norma L.
    Ravindran, Arun V.
    Uher, Rudolf
    [J]. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2016, 61 (09): : 540 - 560
12